Acute retinal necrosis secondary prevention
|
Acute retinal necrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acute retinal necrosis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Acute retinal necrosis secondary prevention |
|
Risk calculators and risk factors for Acute retinal necrosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
Overview
While recurrence of Acute retinal necrosis is not completely preventable presently, administration of topical and intravitreal antiviral therapy targeted to the specific etiological cause of the disease can reduce the chance of recurrence.
Secondary Prevention
While recurrence of Acute retinal necrosis is not completely preventable presently, administration of topical and intravitreal antiviral therapy targeted to the specific etiological cause of the disease can reduce the chance of recurrence.[1]
- Application of antiviral therapy is more effective for prevention when administered as close to disease onset as possible.
- Extensive, prolonged therapy is important in preventing spread of the disease to the unaffected eye.
Further prophylactic measures, such as vitrectomy, may be used in current Acute retinal necrosis patients to minimize the possibility of complications, including retinal detachment.[2]
References
- ↑ Flaxel CJ, Yeh S, Lauer AK (2013). "Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome (an American Ophthalmological Society thesis)". Trans Am Ophthalmol Soc. 111: 133–44. PMC 3868412. PMID 24385671.
- ↑ Shantha JG, Weissman HM, Debiec MR, Albini TA, Yeh S (2015). "Advances in the management of acute retinal necrosis". Int Ophthalmol Clin. 55 (3): 1–13. doi:10.1097/IIO.0000000000000077. PMC 4567584. PMID 26035758.